S. Laohavinij

A Phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid

A. Boddy, S. Wedge, D. Newell, 2004, Investigational New Drugs.

The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309.

W. Prasithsirikul, S. Eiam‐Ong, O. Supasyndh, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Survival and prognostic factors of stage I-III breast cancer.

J. Maneechavakajorn, S. Laohavinij, Ki Ruikchuchit, 2013, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Measurement of 5,10-dideaza-5,6,7,8-tetrahydrofolate (lometrexol) in human plasma and urine by high-performance liquid chromatography.

S. Wedge, D. Newell, S. Laohavinij, 1995, Journal of chromatography. B, Biomedical applications.

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.

T. Yau, Yoon-Koo Kang, I. Tan, 2012, The Lancet. Oncology.

Prognostic factors for survival in advanced non-small cell lung cancer.

J. Maneechavakajorn, S. Laohavinij, 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.

J. Maneechavakajorn, V. Ratanatharathorn, A. Cheirsilpa, 1999, Lung cancer.

Survival and Prognostic Factors of Metastatic Breast Cancer.

K. Maneenil, S. Laohavinij, Vinai Paul, 2017, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Prognostic factors for survival in colorectal cancer patients.

J. Maneechavakajorn, S. Laohavinij, Parapat Techatanol, 2010, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10- dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement.

A. Boddy, S. Wedge, D. Newell, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide.

J. Maneechavakajorn, S. Sa-nguansai, K. Maneenil, 2019, Annals of palliative medicine.

Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET).

T. Hwang, S. Ricci, M. Pavel, 2013 .

Safety and Quality-Of-Life (QOL) Assessments in the Open-Label, Multicenter, Phase 3b, Expanded Access Study of Everolimus in Patients with Advanced Neuroendocrine Tumors (NET)

T. Hwang, S. Ricci, M. Pavel, 2014 .

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.

J. Maneechavakajorn, V. Ratanatharathorn, A. Cheirsilpa, 1999, Lung cancer.